GlassScriptPhysician profile
Vandana Char
NPI 1912985235
$1,090.39
in general payments reported to CMS, 2019-2025
16 companies · $212 in 2025
The $212 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.51 · 2020: $91.89 · 2021: $101 · 2022: $153 · 2023: $194 · 2024: $252 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $299.58 | 2019-2023 | Bexsero |
| Supernus Pharmaceuticals, INC. | $166.87 | 2023-2024 | Qelbree, Qelbree |
| Sanofi Pasteur INC. | $110.63 | 2019-2025 | |
| Pfizer INC. | $83.42 | 2019-2025 | |
| Cranial Technologies, INC | $74.33 | 2021-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $66.30 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $55.14 | 2020-2022 | |
| Adlon Therapeutics L.P. | $48.02 | 2020-2021 | |
| Phadia US INC. | $46.43 | 2021-2025 | Immunocap |
| Cipher Pharmaceuticals US LLC | $34.20 | 2025 | Spinosad, Natroba |
| Astrazeneca Pharmaceuticals LP | $23.86 | 2024 | Flumist Quadrivalent |
| Corium, LLC | $18.32 | 2021 | |
| Nestle Healthcare Nutrition INC. | $18.01 | 2023 | |
| Ironshore Pharmaceuticals INC. | $15.85 | 2020 | |
| Shire North American Group INC | $15.59 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $13.84 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vandana Char listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.